Learn about genetic studies of cognition risks related to Alzheimer's disease in in Mayo Clinic's Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D.
Taner, M.D., Ph.D., who leads Mayo Clinic's Precision Medicine in Neurodegeneration Lab, studies complex genetic interactions in Alzheimer's disease.
Learn about gene expression studies in progressive supranuclear palsy in Mayo Clinic's Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D.
Learn about epigenetic studies related to Alzheimer's disease in Mayo Clinic's Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D.
Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.
Learn how Mayo Clinic's Precision Medicine in Neurodegeneration Lab is studying the genetics of Alzheimer's disease in understudied populations.
Learn about genetics of posterior cortical atrophy studies in Dr. Ertekin-Taner's Precision Medicine in Neurodegeneration Lab at Mayo Clinic.
The CLEAR-AD U19 Scholars Program is a two-year program for early-career Mayo Clinic scientists from groups understudied in biomedical research.
Research teams at Mayo Clinic campuses help patients with medical illness to adapt to their medical conditions and implement positive lifestyle changes.
Several clinical and research programs at Mayo Clinic are examining strategies to improve the delivery of evidence-based mental health treatments.
Mayo Clinic research teams use a multidisciplinary approach to understand and identify factors associated with clinical diagnoses and treatment responses.
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results